Peptides DB
Research-centric peptide and protocol reference hub
Study 12 of 17Abaloparatide (Tymlos) literatureBone · Review2026

Callus geometry as a reflection of fracture healing biology and a candidate imaging biomarker: A systematic review of biological, mechanical, and clinical evidence.

Callus geometry shows promise as a biomarker for fracture healing but requires further clinical validation.

Read at BoneAdd to compare

Where it sits

this study against the rest of the abaloparatide (tymlos) corpus
6
Preclinical
4
Observational
0
Open-label
0
Randomised
7
Reviews · this one

Summary and findings

This systematic review evaluates the potential of fracture callus geometry as an imaging biomarker for fracture healing. It synthesizes evidence from 48 studies on biological, mechanical, and clinical influences on callus formation. Findings suggest callus geometry reflects the healing environment and may predict mechanical strength and clinical outcomes.

How much of this paper we could read: full text read (0.80). We had a clear abstract, so the summary below closely tracks the paper. What this means →
Not reported in abstract.2026

Abstract

The authors’ words, as Bone supplied them

Fracture healing is a complex, multiscale process governed by the interaction between biological activity and mechanical environment, and fracture callus geometry represents an integrated manifestation of these processes. Although callus morphology is routinely assessed during healing, its value as an objective and predictive marker of mechanical competence and clinical outcome has not been systematically established. This review synthesizes current experimental and clinical evidence to clarify the determinants of callus geometry and to evaluate its potential as an early indicator of fracture healing. A systematic review was conducted in accordance with the PRISMA guidelines, using major databases to identify preclinical and clinical studies reporting qualitative or quantitative measures of fracture callus geometry. Eligible studies examined biological, mechanical, systemic, or pharmacologic influences on callus formation, or assessed associations between callus morphology and biomechanical strength or clinical healing outcomes. Extracted data included study design, fracture model, imaging modality, geometric parameters, and functional endpoints. Given substantial heterogeneity in models, measurement techniques, and assessment timing, findings were synthesized narratively. Forty-eight studies met the inclusion criteria. Across species and fracture models, callus geometry consistently reflected the underlying healing environment. Angiogenic and osteoanabolic interventions, including deferoxamine, platelet-rich plasma, and sclerostin inhibition, were associated with larger, more mineralized, or better-organized calluses, highlighting the importance of vascular and osteoblastic signaling. In contrast, chronic PTH or PTHrP stimulation often produced smaller yet structurally organized calluses, underscoring the need to interpret geometric measures within a biological context. Advanced imaging studies demonstrated strong associations between microarchitectural features and mechanical strength, while automated and CT-based methods improved reproducibility and translational feasibility. Non-modifiable factors such as metabolic disease, systemic inflammation, and traumatic brain injury also produced characteristic alterations in callus morphology. Overall, callus geometry emerges as a biologically meaningful and mechanically informative marker of fracture repair. Standardized, quantitative assessment of callus geometry shows promise as a candidate imaging biomarker of healing trajectory and warrants prospective clinical validation before a prognostic role can be established.

Background

Fracture healing is a complex process influenced by biological and mechanical factors, with callus geometry potentially serving as a marker of healing. Despite routine assessment, its predictive value for mechanical competence and clinical outcomes is not well-established. This study aims to evaluate the determinants of callus geometry and its potential as an early indicator of fracture healing.

Methods

A systematic review was conducted following PRISMA guidelines, sourcing studies from major databases. Eligible studies included those examining biological, mechanical, systemic, or pharmacologic influences on callus formation. Data extracted covered study design, fracture model, imaging modality, geometric parameters, and functional endpoints.

Results

The review found that callus geometry consistently reflected the underlying healing environment across species and models. Angiogenic and osteoanabolic interventions were linked to larger, more mineralized calluses, while chronic PTH or PTHrP stimulation resulted in smaller but organized calluses. Advanced imaging studies showed strong associations between microarchitectural features and mechanical strength.

Interpretation

The findings suggest that callus geometry is a meaningful marker of fracture repair, with potential as an imaging biomarker. However, the heterogeneity in study designs and measurement techniques limits the ability to draw definitive conclusions. Further prospective clinical validation is necessary to establish its prognostic role.

Key findings

  • Forty-eight studies met inclusion criteria.
  • Callus geometry consistently reflected the healing environment.
  • Angiogenic and osteoanabolic interventions associated with larger calluses.
  • Chronic PTH stimulation produced smaller yet organized calluses.
  • Advanced imaging showed strong associations with mechanical strength.

Limitations

  • Substantial heterogeneity in models and measurement techniques.
  • Prospective clinical validation needed.
  • Narrative synthesis due to varied study designs.
  • Potential confounding factors not fully addressed.

Elsewhere in the Abaloparatide (Tymlos) corpus

CDMP1-Cre expressing cells mediate the gain in bone mass and strength, but not the increase in bone remodeling, induced by ligands of the parathyroid hormone receptor.Bone research · 2026 · PTH/ABL increased bone mass and strength only in fl/fl littermates.AnimalCParathyroid Hormone Modulates Alveolar Bone Metabolism via Inducing Periodontal Ligament Stem Cells Aerobic Glycolysis.International dental journal · 2026 · Not reported in abstract.AnimalCOxygen‑sensing histone demethylase KDM6A modulates chondrocyte‑to‑osteoblast transdifferentiation by activating the Wnt/β‑catenin pathway.International journal of molecular medicine · 2026 · Not reported in abstract.AnimalCTFF1-mediated suppression of the TCA cycle promotes bone metastasis in triple-negative breast cancer.Translational oncology · 2026 · Deletion of TFF1 reduced metastatic burden and extended survival in mouse models.AnimalDSpatiotemporal complexity and druggability of PTH1R: insights from small molecules and peptides.Molecular and cellular endocrinology · 2026reviewCRestoring cartilage-subchondral bone metabolism with biphasic magnesium microspheres ameliorate early osteoarthritis.Bioactive materials · 2026Animal